The NSW government’s $16.6 million RSV prevention program will cover the cost of nirsevimab (Beyfortus), a monoclonal ...
The RSV prevention program will see the NSW Government fund nirsevimab, a type of monoclonal antibody immunisation, from mid-March for babies who are not protected through maternal vaccination, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback